59
1 Mortality and harm reduction in Cardiff and Vale UHB 25th November 2010

Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

1

Mortality and harm reduction

in Cardiff and Vale UHB

25th November 2010

Page 2: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

2

Driver Diagram

Reduce

Mortality,

Harm,

Variation

and

Waste

Ventilator bundle

Hospital Acquired

Infections

Central & Peripheral Line Insertion &

Maintenance Bundles

Blood stream infections

Clostridium Dificile Bundle

VTEs HAT assessment, prevention and

treatment

Clostridium Dificile

Surgical Errors WHO Checklist

Surgical site infections

Ventilator acquired Pneumonias

Catheter Associated UTI

Stroke care

Leadership for QI

WalkRounds/Patient Safety Fridays

Medicines Management

Reconciliation

High risk medications

Transforming Care

Heart Failure

SKIN Bundle

Falls Prevention

Mental Health

Sepsis/RRAILS

Mortality & Harm Reviews

First episode psychosis

Depression

Dementia

Early Warning Scores & Rapid

ResponseSSI Bundle

Urine Catheter insertion &

maintenance bundles

Pressure Ulcers

Pathways and Bundles

Build Skills Capacity & Capability

Page 3: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

3

GTT Adverse Events RatesAdverse event rate per 1000 patient days

Cardiff and Vale University Health Board - UHW

0.0

10.0

20.0

30.0

40.0

50.0

60.0

70.0

80.0

90.0

100.0

Jul-06

Oct-06

Jan-07Apr-0

7Jul-0

7Oct-0

7Jan-08

Apr-08

Jul-08

Oct-08

Jan-09Apr-0

9Jul-0

9Oct-0

9Jan-10

Rate

Values Average (28.0)

Number of adverse events

Cardiff and Vale University Health Board - UHL

0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

Oct-07

Dec-07

Feb-08

Apr-08

Jun-08

Aug-08

Oct-08

Dec-08

Feb-09

Apr-09

Jun-09

Aug-09

Oct-09

Dec-09

Feb-10

Num

ber

Values Average (4.1)

Page 4: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

4

GTT – Number of triggers

Number of triggers

Cardiff and Vale University Health Board - UHL

0.0

10.0

20.0

30.0

40.0

50.0

60.0

70.0

Oct-07

Dec-07Feb-08

Apr-08

Jun-08

Aug-08Oct-0

8

Dec-08Feb-09

Apr-09

Jun-09

Aug-09Oct-0

9

Dec-09Feb-10

Num

ber

Values Average (43.6)

Number of triggers

Cardiff and Vale University Health Board - UHW

0.0

10.0

20.0

30.0

40.0

50.0

60.0

Jul-06

Oct-06

Jan-07Apr-0

7Jul-0

7Oct-0

7

Jan-08Apr-0

8Jul-0

8Oct-0

8

Jan-09Apr-0

9Jul-0

9Oct-0

9

Jan-10

Num

ber

Values Average (29.0)

Increased triggers have no

correlation with AE rates

Page 5: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

5

Trigger Conversion Rate Monthly Conversion rate

Cardiff and Vale University Health Board - UHW

0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

40.0

45.0

50.0

Jul-06

Oct-06

Jan-07

Apr-07

Jul-07

Oct-07

Jan-08

Apr-08

Jul-08

Oct-08

Jan-09

Apr-09

Jul-09

Oct-09

Jan-10

Perc

enta

ge

Values Average (18.0)

Monthly Conversion rate

Cardiff and Vale University Health Board - UHL

0.0

5.0

10.0

15.0

20.0

25.0

Oct-07

Dec-07

Feb-08

Apr-08

Jun-08

Aug-08

Oct-08

Dec-08

Feb-09

Apr-09

Jun-09

Aug-09

Oct-09

Dec-09

Feb-10

Perc

enta

ge

Values Average (9.0)

Page 6: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

6

GTT – codes for UHWEvents by trigger code

Cardiff and Vale University Health Board - UHW from Jul 06 to

Mar 10

0

5

10

15

20

25

30

L12

G7

G4

G3

G2

G1

S1 L8 L13

L10

S2 L3 L14 L4 G

6G

5 L1 L2 L6 L7 M2

M4

S3 I2 L5 L11

M1

M5

Trigger code

Nu

mb

er

Wound infection

Page 7: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

7

GTT Codes - UHLEvents by trigger code

Cardiff and Vale University Health Board - UHL from Oct 07 to

Mar 10

0

5

10

15

20

25

30

35

40

45

G7

G3

G4

L12

G2

L10

L13

G1

G6

S1 S2 L2 L3 M2 L1 G

8 L5 L6 L8 M1

M5

Trigger code

Nu

mb

er

Complication of procedure or treatment

Page 8: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

8

Learning from GTT

• Similar event rates at both main sites

• More triggers at UHL than UHW average 40: 29

• Increase in triggers is due to increase in general care triggers detected at UHW

• Conversion rate is double at UHW that of UHL (18:9)

• L12 (wound infection) is the highest trigger at UHW

• G7 (complication of treatment) is the highest trigger at UHL

Page 9: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

9

Next steps for GTT

• Better analysis of the data – identify

learning points

• Link the learning from GTT to the learning

from mortality reviews

• Prioritise actions

Page 10: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

10

RAMI• Weekly Deaths Review Group established

– Led by Medical Director, supported by Assistant Medical Directors (x2);

Assistant Director Patient Safety & Quality; Improvement Advisor and

Clinical Coding Manager, Clinical Coder in rotation to inform learning

• Data extracts generated weekly via Clinical Governance Data

Analyst from CHKS, patients whose RAMI suggests least likely

to die (RAMI less than 0.25)

• On average 18 of 45 weekly deaths case notes reviewed

• If triggers identified Medical Director generates letter for lead

Consultant to undertake case review and feedback

• Key learning to date

– Coding Quality improving

– Raising the profile and importance of clinical coding with clinicians and

making some operational changes to working arrangements to

strengthen coder / clinician interface.

Page 11: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

11

Page 12: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

12

CHANGES IN RISK ADJUSTED MORTALITY

60

65

70

75

80

85

90

95

100

105

110

MONTH

ORIGINAL RAMI*

UPDATED RAMI**

ORIGINAL RAMI* 89 104 77 89 88 86

UPDATED RAMI** 81 94 72 77 79

APR MAY JUN JUL AUG SEP

Page 13: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

13

Page 14: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

14

Page 15: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

15

Page 16: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

16

Leadership – WalkRounds• Patient Safety Fridays

introduced during 2009

• Involves c.two Exec and IM WalkRounds per week, over 80 completed

• Covers all of the organisation Initially became a „free for all‟

• Actions logged

• Key recurring themes are staffing and estates/ environments of care issues

• Various criteria applied to prioritise estates issues

• Planned ward refurbishment programme underway

• We also observe and share good practice

Next steps

• Better scheduling and direction of visits i.e more structure

• Maintain the focus on Q&S organisational priorities –Reduction in C.Diff; VTE Risk Assessment; SKIN Bundle; Rapid Response to Acute illness; Improved management/reduction in hospital falls

• Analysis of actions agreed, completed and monitored

• Outcomes reported and scrutinised at Board Level Quality & Safety Committee

• Process continues to be reviewed and is evolving

Page 17: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

17

Patient StoriesStories provide Board with a window into the operational

working of the Health Board

• All Health Board Meetings now commence with a Patient Story

• True stories impact and engage the audience and helps reinforce accountability for ensuring high quality and safe patient care.

The Story is conveyed from the perspective of the Patient and their experience

Stories are a mix of good and not so good experiences

• Quality and Safety Committee meetings commence with a Patient Story from a Division. Divisional Q&S meetings are increasingly making use of Patient Stories

Stories capture the learning and is aligned to Fundamental of Care Standards or Standards for Health in Wales

• Ensuring action in response to stories is a priority for the UHB Stories capture the learning from the experience and outlines the action taken in

response to the patient feedback

Powerful method of ensuring the focus of Board

level meetings

Page 18: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

18

Capacity and Capability

• Leading to Deliver programme for all new Directorate teams

• Establishing a „Faculty‟

• Staff Culture Survey – already commenced in Primary Care

• Model for Improvement incorporated in other programmes e.g. Care to Lead for ward sisters, Transforming Care, SKIN Bundle roll out and through attendance at 1000 Lives Plus learning events.

Page 19: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

19

C-dificile actions

• C-dif group established

• UHB action plan in place

• All divisions have an action plan

• Antibiotic sticker developed to guide the process and make adherence more intuitive

• Organisation – wide antibiotic stewardship –cefuroxime and ciprofloxin prescribing ceased on 1st

June 2010

• Audit/measurement tool developed. First audit completed – awaiting results – great variation in practice at present.

Page 20: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

20

Improvement is encouraging

This SPC Chart demonstrates that if we analysed the data (Oct 2010), we find a mean reduction from 70.9 to 39.5, that is a mean

reduction by 44%.

Page 21: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

21

• Documentation of Antimicrobial prescription in the notes.

• Review of antimicrobial Prescriptions by Consultant

responsible for the patient within 72 hours

• Antimicrobial prescriptions for > 7 days must be resigned

and reasons indicated in the patient record.

• Compliance with UHB antimicrobial policy

Page 22: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

22

Restrictive AB

formulary• Within Cardiff and Vale UHB antimicrobials are divided

into 3 main categories:

– A freely available across Secondary Care

– B freely available within specific units/ for specific indications (outside those units/indications treat as category C)

– C available only with agreement of Consultant Microbiologist (or other nominee)

Page 23: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

23

Page 24: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

24

Page 25: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

25

WHO ChecklistProcedures where WHO Checklist was completed

0

500

1000

1500

2000

2500

Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10

month

nu

m b

er

of

pro

ced

ure

s

0.00

20.00

40.00

60.00

80.00

100.00

120.00

%

Number of

surgical

procedures

%

completion of

WHO

checklist

Data recording

processes unclear

Achieving reliability

Page 26: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

26

Peri-Op normothermia% Procedures where peri-operative normothermia was

maintainted

0

500

1000

1500

2000

2500

Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10

month

Nu

mb

er o

f p

roce

du

res

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

% n

orm

oth

erm

ic

Number of

surgical

procedures

% patients

where

normothermia

was

maintained

Page 27: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

27

Hospital Acquired Thrombosis

Organisational Priority

Executive sponsorship and establishment of

Working/Steering Group

Jan 2010 – Working Group outline

Feb 2010 – TaAG agreed

March 2010 – New terms of reference report to

Quality and Safety Committee

Page 28: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

28

Page 29: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

29

Thromboprophylaxis

• 21st October – UHB audit on assessment

and treatment by junior doctors.

• Presentation to Thrombosis Group 18th

November 2010.

• Audit outcome will help focus actions for

change.

Page 30: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

30

PLASMAscreens

HAT

Promotion

Via

Patient Line

Patient Leaflets

Page 31: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

31

The next phaseMeasure

• Re audit compliance with risk assessment tool and prescribing

• Rates of VTE

• Complications of thromboprophylaxis

Development of further protocols for VTE prevention

• Psychiatric patients

• Nursing home patients

Education and training

• Undergraduate programme

• Postgraduate programme

• Pharmacists

• GP‟s

Page 32: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

32

Medicines reconciliation 1

Ongoing monthly data collection for all new admissions -

% patients with no reconciliation within 24 hours

Sequential days provide “virtual weeks” to highlight

impact of week-end service etc.

Page 33: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

33

Medicines reconciliation 2

Primary care MUR‟s

targeted to patients with

identified reconciliation

issues post discharge. Pilot

project.

Page 34: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

34

High risk drugs – anticoagulants -1

1. Ongoing run charts of reported INR‟s >5 and >8

2. MSc data analysis of anticoagulant associated major bleeds and impact of SPI2/1,000 lives (+)

Methodology may be transferable to other LHB‟s.

Page 35: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

35

High risk drugs – anticoagulants 2

3. Audit of causes for INR’s >5 and treatment given• Majority of high INR‟s on established therapy,

• Only half of “counselled” patients could recall important aspects,

• Multi factorial or new/worsening disease state most common reason,

• 12% around time of initiation,

• 18% following new medication,

• Advice on treatment only followed about 50% of time

4. Survey on communication with primary care

• Newer style form preferred

• Information received by more than one route 51%

• Fax route preferable 65%

• Information always arrives in good time 19%

• Information sometimes arrives in good time 78%

• Forms always filled in correctly 38%

• Forms sometimes filled in correctly 54%

• Obvious contact for queries 81%

• Discharge at weekends and before patient apparently stable raised as concerns

Page 36: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

36

High risk drugs - Insulins

Insulin prescription

administration chart in

use with patient safety

issues from MSc FMEA

“Hypo pack” introduced

on wards following new

national guidance –

supported by training of

medical and nursing staff

Page 37: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

37

Acute Stroke Services Action Plan

• Executive-led multi-disciplinary steering group to drive improvements

• Enhanced medical and nursing establishment to support service

development

• Ring-fenced specialist beds on UHW ward C7 acute stroke unit

• Revised bed management protocols to ensure timely transfer of acute

admissions to unit (24 hour compliance has increased from less than 10%

to over 80% since May this year)

• High levels of compliance with WAG intelligent targets for acute stroke

services, delivering a range of evidence-based clinical interventions across

3 hour, 24 hour, 3 day and 7 day care bundles

• High levels of clinical and managerial ownership and commitment has been

critical to achieving service improvements

Page 38: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

38

Stroke Thrombolysis Action Plan

• Strong evidence base for delivery of thrombolysis for acute stroke patients within 3 hours of symptom onset

• Successful implementation requires rapid specialist assessment, diagnostics and careful monitoring post-treatment

• Monday – Friday service established in 2008 following development of protocols

• 24/7 service commenced in September 2010 within Cardiff and Vale, using specialist stroke physician rota

• WAG programme to rollout across Wales, using regional consultant rotas and telemedicine technology

• Door to needle time of less than one hour now being achieved

• Regular service audit / review to eliminate delays and ensure best practice

• Ongoing public awareness and inter-service co-operation is key to ensuring prompt attention and treatment to save lives and reduce disability

Page 39: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

39

TIA Action Plan

• Key role of TIA service as stroke secondary prevention

• Multi-disciplinary task and finish group to drive service improvements, with close primary care liaison

• Establishment of integrated cross-site service to eliminate variation, with one point of referral

• Establishment of daily clinics, with rapid access philosophy

• Urgent cases now seen in clinic within 48 hours

• Revised diagnostic support to achieve „one stop shop‟

• Revised out of hours protocol to reinforce 7 day philosophy

• Urgent surgery referrals actioned within two weeks

• New database from November to assess service quality and timeliness against new target standards

Page 40: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

40

Stroke Services – Conclusions

• Stroke service improvements started from a very low base in 2007

• Central and local commitment to improvements as a priority

• A lot has already been achieved, particularly stroke being seen as a true medical emergency

• More remains to be done, against a very challenging financial background

• But stroke is now getting the priority and commitment that it deserves, and stroke patients have a greatly improved service

Page 41: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

41

IPC Bundles

• Central Lines – spreading beyond critical care.

• Urine Catheter bundles tested.

• Group established to roll out

• PVC bundles tested in critical care. Team developed for testing bundle outside critical care.

• Ventilator bundle well established.

Page 42: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

42

Pressure ulcers - SKIN

Bundle

• Tested and implemented on critical care

• C&V Faculty established to deliver education, training and mentoring

• Roll out plan via C&V mini collaborative approach including community nursing and nursing homes

Page 43: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

43

hunches,

theories &

ideas

changes that result

in improvement

Pressure Ulcers –Testing and

Implementing SKIN Bundle

Plan

SKIN bundle

used with one

patient

All patients in the

intensive care

area

SKIN bundle used for all

patients in the CCU

PDSA cycles

enabled

•Refinement of the

SKIN bundle visual aid

•Feedback on

compliance rates

•Targeted education

•Measure outcomes

using safety cross

Page 44: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

44

SKIN bundle and safety cross

to prevent pressure ulcer

acquisition in critical care

University Hospital Llandough

Page 45: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

45

Project aim

• To ensure that all patients at risk of developing pressure ulcers were identified.

• To reliably implement prevention strategies identified in the Prevention and Treatment of Pressure Ulcers Guide (NIHCE 2005).

• To reduce the number of hospital acquired pressure ulcers by 50% of the baseline by 2010

Page 46: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

46

Methodology

• Baseline audit of practice

• Introduction of the „safety cross‟ to record and understand pressure sore acquisition

• Introduction of the „SKIN bundle‟ to ensure consistent delivery of evidence based care

• Measure compliance and patient outcomes

• Focused and targeted education

Page 47: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

47

SAFETY CALENDAR MONTH: May

Date of last Pressure Ulcer

7 8 11 1213 14 17 1819 20 23 24

3129 30

246

101622

2628

1521

2527

13

9

5

17

Ward acquired: 18th May

Admitted with: 21st May X

No new case

identified

Admitted with

New case

identified 21

Recording pressure ulcers using the

Safety Cross

Page 48: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

48

Safety cross

• Is visible – it demonstrates that we are committed

to measuring and improving our care

• It doesn‟t replace the safety reporting system - it

enables us to more efficiently comply

• Prevents staff becoming desensitised to unsafe

practices

• Enables analysis of all pressure ulcer acquisition

Page 49: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

49

Delivering reliable care –

the SKIN bundle

• A bundle is a set of evidence based practices that when performed collectively and reliably improve patient outcomes

• SKIN bundle

– Surface selection

– Keep turning and moving

– Manage Incontinence and moisture

– Monitor Nutrition and fluid intake

Page 50: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

50

SKIN bundle

Waterlow

At risk? *Yes/No

D/T N/T

Surface Mattress Repose boots TEDs/Heel check

Keep moving Position change ___________ hrly

Incontinence Yes/No Barrier cream

Consider f lexiseal

Nutrition

WASSP > 7 High Risk

NG/ TPN/ Food chart

Using a visual reminder we daily:-

• Evaluate and document risk

assessments

• Ensure all patients receive the

most appropriate care e.g.

monitor food intake

• Document deviations from best

practice, e.g. when patients do

not consent to interventions

• Audit practice – monitor what we

are doing well and how we can

improve

Page 51: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

51

Results – Compliance with the SKIN bundle

Achieving reliability

Spreading too soon

Testing sticker compliance

Page 52: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

52

Results – days between pressure ulcers

0

20

40

60

80

100

120

14010

May

09

18 M

ay 0

9

01 J

un 0

9

10 J

ul 0

9

14 J

ul 0

9

28 A

ug 0

9

13 S

ep 0

9

04 O

ct 0

9

03 N

ov 0

9

24 F

eb 1

0

30 A

pr 1

0

28 J

un 1

0

15 S

ep 1

0

Day

s b

etw

een

eve

nts

Values Median (38.0)Lower (0.0) Upper (122.8)

At the beginning of this project we had a unit acquired pressure ulcer (grade 2 – 3)

every 12 days we have increased days between damage to 38 days (median) and

have not had any pressure damage for 55 days

113 days between

Page 53: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

53

Team work

Page 54: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

54

Community Nursing -

Pressure Damage

2009/10

• 315,000 visits made to patients

• 40,000 Referrals made to

the service

• Caseload of 5600

• Pressure ulcer incidence of 5.6%

Page 55: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

55

Opportunity/Challenges for community nursing

• To reduce incidence of Pressure damage

• Improve patient experience and quality of

patient care

• Promote self care and patient empowerment

• Identify stakeholders

• Identify and evidence any constraints

in system

• Ensure timely access to equipment

• Develop documentation to support SKIN

Bundle methodology

Page 56: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

56

St Albans Care HomePressure Damage – Our Story by Ruth Young, Matron

St Albans is an independent, privately owned care home based in Cardiff.

It has 40 beds comprising of nursing, continuing health care and complex care needs.

Our clients……

Page 57: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

57

Our Pressure Damage History Much like many care homes, our pressuredamage story was a difficult one to tell with…

• Numerous cases of pressure damage of allgrades;

• The most severe cases proceeding to POVAs,Inquests and litigation;

• Staff struggling to cope with the stress ofinvestigations;

• Uncomfortable clients and distressed relatives.

Page 58: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

58

The Need For Change

Change was needed so that we could be confident that we were delivering the best care possible to our clients and we focused on the following:

• Documentation (implemented Daily Skin Check Chart for Carersand Prevention/Detection Treatment Regime and regular audit of these);

• Culture/Staff Responsibility (Skin Champions identified to oversee the quality of documentation/consistency of grading and to instigate care regimes);

• Product Availability (ensured all clients had access to Airflow mattresses).

Page 59: Mortality and harm reduction in Cardiff and Vale UHB · 3 GTT Adverse Events Rates Adverse event rate per 1000 patient days Cardiff and Vale University Health Board - UHW 0.0 10.0

59

The Next Chapter

As a result of these changes, we are now proudly able to say that we are a care home free from avoidable pressure damage with a committed team confident in this knowledge.

We are the first care home to be part of the SKIN Bundle work and have shared our experience and knowledge to produce the tools to help others get where we are today.